Federico Grossi - Jan 12, 2022 Form 4 Insider Report for Apellis Pharmaceuticals, Inc. (APLS)

Role
CHIEF MEDICAL OFFICER
Signature
/s/ David Watson, attorney-in-fact for Dr. Federico Grossi
Stock symbol
APLS
Transactions as of
Jan 12, 2022
Transactions value $
$20,230
Form type
4
Date filed
1/14/2022, 03:57 PM
Previous filing
Jan 4, 2022
Next filing
Jan 19, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APLS Common Stock Options Exercise $13.8K +3.66K +5.2% $3.76* 74K Jan 12, 2022 Direct
transaction APLS Common Stock Options Exercise $6.47K +1.5K +2.03% $4.31* 75.5K Jan 12, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction APLS Stock Option (Right to Buy) Options Exercise $0 -3.66K -100% $0.00* 0 Jan 12, 2022 Common Stock 3.66K $3.76 Direct F1
transaction APLS Stock Option (Right to Buy) Options Exercise $0 -1.5K -2.13% $0.00 68.8K Jan 12, 2022 Common Stock 1.5K $4.31 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This stock option was granted on 02/08/2016 and is fully vested.
F2 This stock option was granted on 08/21/2017 and is fully vested.